Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma
By:
News Direct
March 09, 2023 at 07:53 AM EST
--News Direct--
Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new report on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), following the release of selected data from its human volunteer LPS challenge trial for lead molecule POLB 001.
Contact Details
Proactive UK Ltd
+44 20 7989 0813
View source version on newsdirect.com: https://newsdirect.com/news/proactives-robin-davison-publishes-fresh-research-note-on-poolbeg-pharma-346100498
More News
View More
MP Materials Stock Soared After Earnings—Here’s the Real Reason ↗
November 22, 2025
Via MarketBeat
Why Palantir Slide May Be a Setup for a Long-Term Opportunity ↗
November 22, 2025
Via MarketBeat
Attention Income Investors: This REIT Is on Sale ↗
November 22, 2025
Rocket Lab Just Had Its First Real Crash—The Rebound Could Be Bigger ↗
November 22, 2025
Via MarketBeat
Tickers
RKLB
MarketBeat Week in Review – 11/17 - 11/21 ↗
November 22, 2025
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>